litlas
Log inCreate account

Jeffrey Borer

Active 1974–2022

87
Papers
26,584
Citations
79
h-index
87
i10-index

Citations

Citations per year for Jeffrey Borer1944: 1 citations1947: 1 citations1975: 4 citations1976: 11 citations1977: 16 citations1978: 50 citations1979: 71 citations1980: 54 citations1981: 70 citations1982: 36 citations1983: 54 citations1984: 54 citations1985: 35 citations1986: 43 citations1987: 62 citations1988: 57 citations1989: 67 citations1990: 86 citations1991: 38 citations1992: 48 citations1993: 65 citations1994: 58 citations1995: 70 citations1996: 54 citations1997: 52 citations1998: 62 citations1999: 68 citations2000: 50 citations2001: 34 citations2002: 38 citations2003: 62 citations2004: 41 citations2005: 72 citations2006: 104 citations2007: 70 citations2008: 96 citations2009: 83 citations2010: 91 citations2011: 110 citations2012: 127 citations2013: 161 citations2014: 145 citations2015: 143 citations2016: 144 citations2017: 152 citations2018: 154 citations2019: 567 citations2020: 574 citations2021: 531 citations2022: 382 citations2023: 248 citations2024: 407 citations2025: 154 citations2026: 3 citations1945–1946: no citations, so these years are not shown1948–1974: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,324 citing papers, 26.1% of this breakdownUnited Kingdom: 695 citing papers, 7.8% of this breakdownItaly: 578 citing papers, 6.5% of this breakdownGermany: 484 citing papers, 5.4% of this breakdownChina: 408 citing papers, 4.6% of this breakdownCanada: 401 citing papers, 4.5% of this breakdownFrance: 322 citing papers, 3.6% of this breakdownNetherlands: 287 citing papers, 3.2% of this breakdownJapan: 274 citing papers, 3.1% of this breakdownAustralia: 251 citing papers, 2.8% of this breakdownSpain: 236 citing papers, 2.7% of this breakdownSweden: 216 citing papers, 2.4% of this breakdown
0%26.1%Other 27.3%

Institutions

Fields

  • Medicine86.7%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Engineering1.8%
  • Immunology and Microbiology1.5%
  • Neuroscience0.8%
  • Health Professions0.6%
  • Other3.7%

Topics

  • Cardiovascular Function and Risk Factors6.9%
  • Heart Failure Treatment and Management5%
  • Cardiac Imaging and Diagnostics3.5%
  • Heart Rate Variability and Autonomic Control3.4%
  • Cardiac Valve Diseases and Treatments3%
  • Acute Myocardial Infarction Research2.7%
  • Other75.5%

Coauthors

All papers

Open in search
  1. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

    Authors: William B. White, Kenneth G. Saag, Michael A. Becker, Jeffrey Borer, Philip B. Gorelick, Andrew Whelton, Barbara Hunt, Majin Castillo, Lhanoo Gunawardhana - New England Journal of Medicine 2018 cited by 891

  2. Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

    Authors: Douglas L. Mann, John J.V. McMurray, Milton Packer, Karl Swedberg, Jeffrey Borer, Wilson S. Colucci, Jacques Djian, Helmut Drexler, Arthur M. Feldman, Lars Køber, Henry Krum, Peter Liu, Markku S. Nieminen, Luigi Tavazzi, Dirk Jan van Veldhuisen, Anders Waldenström, Marshelle Warren, Arne Westheim, Faı̈ez Zannad, Thomas R. Fleming - Circulation 2004 cited by 1,230

  3. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

    Authors: Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi - The Lancet 2010 cited by 2,554

  4. Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations

    Authors: Konstantinos Dean Boudoulas, Jeffrey Borer, Harisios Boudoulas - Cardiology 2015 cited by 1,944

  5. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

    Authors: Steven E. Nissen, Neville D. Yeomans, Daniel H. Solomon, Thomas F. Lüscher, Peter Libby, M. Elaine Husni, David Y. Graham, Jeffrey Borer, L Wiśniewski, Katherine E. Wolski, Qiuqing Wang, Venu Menon, Frank Ruschitzka, Michael Gaffney, Bruce Beckerman, Manuela Berger, Weihang Bao, A. Michael Lincoff - New England Journal of Medicine 2016 cited by 852

  6. Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex

    Authors: Frank Ruschitzka, William T. Abraham, G. André Ng, Jeroen J. Bax, Jeffrey Borer, Josép Brugada, Kenneth Dickstein, Ian Ford, John Gorcsan, Daniel Gras, Henry Krum, Peter Søgaard, Johannes Holzmeister - New England Journal of Medicine 2013 cited by 817

  7. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

    Authors: Michael Böhm, Karl Swedberg, Michel Komajda, Jeffrey Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi - The Lancet 2010 cited by 1,102

  8. Resting Heart Rate in Cardiovascular Disease

    Authors: Kim Fox, Jeffrey Borer, A. John Camm, Nicolas Danchin, Roberto Ferrari, J. López Sendón, Philippe Gabríel Steg, Jean‐Claude Tardif, Luigi Tavazzi, Michał Tendera - Journal of the American College of Cardiology 2007 cited by 1,063

  9. Meta-Analysis of the Relation of Body Mass Index to All-Cause and Cardiovascular Mortality and Hospitalization in Patients With Chronic Heart Failure

    Authors: Abhishek Sharma, Carl J. Lavie, Jeffrey Borer, Ajay Vallakati, Sunny Goel, Francisco López-Jiménez, Armin Arbab‐Zadeh, Debabrata Mukherjee, Jason Lazar - The American Journal of Cardiology 2015 cited by 437

  10. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

    Authors: James H. Chesebro, Genell L. Knatterud, Robert Roberts, Jeffrey Borer, Lawrence S. Cohen, James E. Dalen, Harold T. Dodge, Charles K. Francis, David Hillis, Philip A. Ludbrook - Circulation 1987 cited by 2,252

  11. Cardiovascular Drug Development

    Authors: Christopher B. Fordyce, Matthew T. Roe, Tariq Ahmad, Peter Libby, Jeffrey Borer, William R. Hiatt, Michael R. Bristow, Milton Packer, Scott M. Wasserman, Ned Braunstein, Bertram Pitt, David L. DeMets, Katharine Cooper‐Arnold, Paul W. Armstrong, Scott D. Berkowitz, Robert C. Scott, Jayne Prats, Zorina S. Galis, Norman Stockbridge, Eric D. Peterson, Robert M. Califf - Journal of the American College of Cardiology 2015 cited by 204

  12. Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease

    Authors: Michael Böhm, Jan‐Christian Reil, Prakash Deedwania, Jae B. Kim, Jeffrey Borer - The American Journal of Medicine 2014 cited by 247

  13. Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study

    Authors: Inger Ekman, Olivier Chassany, Michel Komajda, Michael Böhm, Jeffrey Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg - European Heart Journal 2011 cited by 208

  14. Incremental Benefit of Drug Therapies for Chronic Heart Failure with Reduced Ejection Fraction: A Network Meta-Analysis

    Authors: Michel Komajda, Michael Böhm, Jeffrey Borer, Ian Ford, Luigi Tavazzi, Matthieu Pannaux, Karl Swedberg - European Journal of Heart Failure 2018 cited by 139

  15. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles

    Authors: Gregg W. Stone, Alec Vahanian, David Adams, William T. Abraham, Jeffrey Borer, Jeroen J. Bax, Joachim Schöfer, Donald E. Cutlip, Mitchell W. Krucoff, Eugene H. Blackstone, Philippe Généreux, Michael J. Mack, Robert J. Siegel, Paul Grayburn, Maurice Enriquez‐Sarano, Patrizio Lancellotti, Gerasimos Filippatos, A. Pieter Kappetein - Journal of the American College of Cardiology 2015 cited by 232

  16. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial

    Authors: Frank Ruschitzka, Jeffrey Borer, Henry Krum, Andreas J. Flammer, Neville D. Yeomans, Peter Libby, Thomas F. Lüscher, Daniel H. Solomon, M. Elaine Husni, David Y. Graham, Deborah Davey, L Wiśniewski, Venu Menon, Rana Fayyad, Bruce Beckerman, Dinu Iorga, A. Michael Lincoff, Steven E. Nissen - European Heart Journal 2017 cited by 121

  17. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

    Authors: Michael Böhm, Jeffrey Borer, Ian Ford, José Ramón González‐Juanatey, Michel Komajda, José López‐Sendón, Jan‐Christian Reil, Karl Swedberg, Luigi Tavazzi - Clinical Research in Cardiology 2012 cited by 248

  18. Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT study

    Authors: Luigi Tavazzi, Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey Borer, Mitja Lainščak, Michele Robertson, Ian Ford - International Journal of Cardiology 2013 cited by 101

  19. Relationship of Body Mass Index With Outcomes After Transcatheter Aortic Valve Replacement: Results From the National Cardiovascular Data–STS/ACC TVT Registry

    Authors: Abhishek Sharma, Carl J. Lavie, Sammy Elmariah, Jeffrey Borer, Samin K. Sharma, Sreekanth Vemulapalli, Babatunde A. Yerokun, Zhuokai Li, Roland Matsouaka, Jonathan D. Marmur - Mayo Clinic Proceedings 2020 cited by 59

  20. Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial

    Authors: Kenneth G. Saag, Michael A. Becker, William B. White, Andrew Whelton, Jeffrey Borer, Philip B. Gorelick, Barbara Hunt, Majin Castillo, Lhanoo Gunawardhana, CARES Investigators - Arthritis & Rheumatology 2022 cited by 24

  21. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy

    Authors: Jean‐Claude Tardif, Eileen O’Meara, Michel Komajda, Michael Böhm, Jeffrey Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg - European Heart Journal 2011 cited by 301

  22. Selective Heart Rate Reduction With Ivabradine Unloads the Left Ventricle in Heart Failure Patients

    Authors: Jan‐Christian Reil, Jean‐Claude Tardif, Ian Ford, Suzanne M. Lloyd, Eileen O’Meara, Michel Komajda, Jeffrey Borer, Luigi Tavazzi, Karl Swedberg, Michael Böhm - Journal of the American College of Cardiology 2013 cited by 122

  23. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.

    Authors: Jeffrey Borer, Lee S. Simon - Arthritis Research & Therapy 2005 cited by 99

  24. The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial

    Authors: Jan Steffel, Michele Robertson, G. André Ng, William T. Abraham, Jeroen J. Bax, Jeffrey Borer, Kenneth Dickstein, Ian Ford, John Gorcsan, Daniel Gras, Henry Krum, Peter Søgaard, Johannes Holzmeister, Josép Brugada, Frank Ruschitzka - European Heart Journal 2015 cited by 78